• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Device Problem No Apparent Adverse Event (3189)
Patient Problem Rupture (2208)
Event Date 09/12/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).A review of the manufacturing records for the device(s) could not be performed as item and lot numbers are unknown.Per the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to aneurysm enlargement and rupture.Per ifu, ¿in addition to the risks and benefits of endovascular repair, the physician should assess the patient¿s commitment and compliance to post-operative follow-up as necessary to ensure continuing safe and effective results.¿ additionally, the ifu states ¿all patients should be advised this treatment modality requires long-term, regular follow-up to assess patient¿s health status and stent-graft performance.¿.
 
Event Description
On an unknown date in 2011, the patient was implanted with a gore® excluder® aaa endoprosthesis (item and lot number unknown) to treat an abdominal aortic aneurysm.According to the report, the patient was subsequently lost to follow-up.On (b)(6) 2017, the patient presented emergently to the facility with abdominal pain.An examination revealed a ruptured left common iliac artery.According to the report, aortoiliac disease progression led to vessel dilation and rupture.The patient was implanted with two non-gore manufactured endografts to treat the rupture.The rupture was resolved and the patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WOODY MOUNTAIN B/P
3750 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
damon jackson
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6870559
MDR Text Key86419796
Report Number2017233-2017-00474
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/15/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age91 YR
-
-